CTY
NASDAQCity Therapeutics Inc.
City Therapeutics Inc. (CTY) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for CTY, including 2 press releases and news items and 1 13D/G filing. The most recent was published Nov 6, 2026.
News · 26 weeks3+100%
2026-05-172026-11-08
Mix390d
- Other2(67%)
- 13D/G1(33%)
Activity · 52 weeks33 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
3 items- 13D/GSEC Form SCHEDULE 13G filed by City Therapeutics Inc.SCHEDULE 13G - CITY THERAPEUTICS, INC. (0002143850) (Subject)
- PRPhase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual MeetingCAMBRIDGE, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (NASDAQ:CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced that data from its CITY-FXI and CITY-TFR2 programs will be presented at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12–15, 2026, in New Orleans, Louisiana. An oral presentation will highlight data from the ongoing Phase 1 clinical trial of CITY-FXI, an RNAi therapeutic candidate targeting Factor XI (FXI) for thromboembolic diseases. These data will include results from the single-ascending dose (SAD) cohorts of healthy volunteers (Part
- PRCity Therapeutics to Present at Upcoming November Investor ConferencesCAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (NASDAQ:CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced that management will participate in the following investor conferences in November. Stifel 2026 Healthcare ConferenceFireside Chat: Tuesday, November 10, 2026, at 10:00 a.m. ETLocation: New York, New York Jefferies Global Healthcare Conference in LondonPresentation: Monday, November 16, 2026, at 1:00 p.m. GMTLocation: London, England Live webcasts of the fireside chat and presentation will be available on the "News & Events" page within the Investors section of the City The
CTY FAQ
7 questionsWhat does City Therapeutics Inc. do?
City Therapeutics is a clinical-stage biotechnology company engineering the next generation of RNA interference (RNAi) therapeutics, with the aim of delivering meaningful and durable benefits for patients in need. City's lead development programs are CITY-FXI for thromboembolic diseases, CITY-RBP4 for Stargardt disease and other retinal diseases, and CITY-TFR2 for anemia associated with chronic diseases. The City Platform is the engine behind every therapeutic the company develops and integrates deep expertise in trigger engineering, including proprietary cityRNA triggers designed to address...What is the latest news on CTY?
In the last 30 days Quantisnow tracked 3 wire items for CTY: 2 press releases and news items and 1 13D/G filing. The most recent was published on November 6, 2026.Where does CTY stock trade?
City Therapeutics Inc. (CTY) is listed on NASDAQ.What sector and industry is CTY in?
City Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did City Therapeutics Inc. go public?
City Therapeutics Inc. (CTY) completed its IPO in 2026.What companies are similar to CTY?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare CTY side-by-side with any of them on Quantisnow.How can I track CTY on Quantisnow?
Quantisnow aggregates City Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CTY to receive live email and push alerts on every new disclosure.